New Staff Update – October 2017

-

Welcome to the following CCTO staff:

Aser Abrha

Clinical Research Coordinator Associate, GI

 
Brandon Doan

Clinical Research Coordinator Associate, Lymphoma

 
Priyanka Kedia

Clinical Research Coordinator Associate, Cooperative Group

 
Andreas Lau

Clinical Research Coordinator Associate, Head & Neck

 
Olga Livingston

Clinical Research Coordinator Associate, Cooperative Group

 
Kristen Piasecki

CCTO HR Administrator

 
Rohil Taggarsi

Clinical Research Coordinator Associate, Radiation Oncology

 
Vivian Tsang

Clinical Research Coordinator Associate, Thoracic

 

Information about new CCTO committees

-

CCTO Quality Standards on Education Committee (QSE)

This is a team that will develop, refine, and maintain the CCTO educational program through time. Our first objective will be to define what new staff should be able to do when they finish an onboarding program. From there, we’ll gather information on existing clinical research educational programs and resources throughout the University. The hope is to better integrate with existing educational programs and create a learner-controlled program for training. We will also work on updating the program based on changes to the SOPs and continuing education for ongoing staff.

CCTO Quality Standards on Standard Operating Procedures and Guidelines Committee (QSSG)

This will be a group of individuals in diverse roles across different groups within the CCTO. We will work collaboratively to develop and maintain SOPs, applicable guidelines and tools. You must have the drive for improving processes to help direct your peers to perform research in compliance with regulations and GCP. You must not be afraid of doing yeoman’s work!

If you are interested in participating in either, we encourage you to discuss with your manager.
For QSSG: Sophie Bertrand
For QSE: Ben Priestley

Important Reminder About Building Security

-

CCTO staff, please review the below reminder about building security.

1070 Arastradero:
Although 1070 Arastradero is open to the general public due to the downstairs sandwich shop, you should still be aware of anyone who is walking around on the 3rd floor and in common areas who looks like they do not belong there. If this is the case, and if you feel safe, please ask if they need assistance.

For help finding a certain group/person/room, you can contact Dana Waller who works at the front of the building at 650-723-6254. If safety is a concern you can call Stanford Security at 650-723-9633.

800 Welch Road:
There have been many instances when individuals without a building badge and who were not being properly accompanied by a staff member accessed the 2nd/3rd floors of 800 Welch Road. This is a secure building and we need to be mindful of safety as well as privacy issues. Staff are reminded not to let anyone upstairs who is not escorted or a known staff/faculty member.

For more information, … Full Story>

New FDA-approved Drug Yescarta available at Stanford for Non Hodgkin’s Lymphoma

-

Last night’s broadcast on KTVU featured an interview with Dr. Miklos about a new immunotherapy drug, Yescarta. KGO TV also interviewed Dr. Miklos and Dr. Mackall as well as two patients who contributed moving stories about their experience with Yescarta. The KTVU segment can be viewed below.

Yescarta (axicabtagene ciloleucel) is a chimeric antigen receptor (CAR) T cell therapy, and is the second gene therapy approved by the FDA and the first for certain types of non-Hodgkin lymphoma (NHL). More information can be found on the FDA’s press release.

For the next year Stanford will be the only cancer center providing Yescarta in northern California, and one of only three treatment centers on the west coast (the others are Fred Hutchinson Cancer Research Center, Seattle WA; and City of Hope, Duarte, CA). Many thanks to the Cancer Cell Therapy team and Dr. Miklos for their work on the Kite Pharma trials studying this drug.